Close Menu

NEW YORK (360Dx) – Finnish infectious disease testing firm ArcDia International today announced an exclusive licensing deal with Xinhua Healthcare Industry for ArcDia's biochemical assay components.

ArcDia also will provide Xinhua with research and development services as part of the deal, which is limited to China. Financial and other terms of the agreement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.